Michael Megaly, MD, MS1,2,3; Santiago Garcia, MD1,3; Lucille E. Anzia, BS3; Pamela Morley, RN3; Ross Garberich, MS3; Charles C. Gornick, MD1,3; John Lesser, MD1,3; Paul Sorajja, MD1,3; Mario Gössl, MD, PhD1,3; Jay Sengupta, MD1,3
Michael Megaly, MD, MS1,2,3; Santiag...
We aimed to identify the actual cumulative incidence of new-onset atrial fibrillation/atrial flutter in patients who required pacemaker insertion after TAVR using pacemaker device interrogation.
We aimed to identify the actual cumulative incidence of new-onset atrial fibrillation/atrial flutter in patients who required pacemaker insertion after TAVR using pacemaker device interrogation.